Nutritional therapies (including fosteum)

Current Osteoporosis Reports

Volumn 7, Issue 1, 2009, Pages 5-11

  Nieves, Jeri W ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; ESTROGEN; FARNOQUINONE; FOSTEUM; GENISTEIN; ISOFLAVONE; NUTRACEUTICAL; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHYTOMENADIONE; PLACEBO; PROGESTERONE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN K GROUP; PHYTOESTROGEN;

BONE DENSITY; BONE MINERAL; BREAST TENDERNESS; BYPASS SURGERY; CALCIUM ABSORPTION; CALCIUM DEFICIENCY; CALCIUM INTAKE; CANCER PATIENT; CAUSE OF DEATH; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; ELDERLY CARE; EVIDENCE BASED MEDICINE; FRACTURE; GASTROINTESTINAL SYMPTOM; HUMAN; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POPULATION RISK; POSTMENOPAUSE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SURGICAL PATIENT; VAGINA BLEEDING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ADULT; BONE; CHILD; DRUG EFFECT; ELEMENTAL DIET; METABOLIC BONE DISEASE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PHYSIOLOGY;

ADULT; BONE AND BONES; BONE DISEASES, METABOLIC; CALCIUM; CHILD; FOOD, FORMULATED; FRACTURES, BONE; GENISTEIN; HUMANS; NUTRITION ASSESSMENT; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; OSTEOPOROSIS; PHYTOESTROGENS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 65449135618     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-009-0002-7     Document Type: Review

References (37)

1. Heaney RP, Abrams S, Dawson-Hughes B, et al.: Peak bone mass. Osteoporos Int 2000, 11:985-1009.
2. Nieves J, Cosman F, Lindsay R: Primary osteoporosis. In Disorders of Bone and Mineral Metabolism, edn 2. Edited by Coe FL, Favus MJ. Philadelphia: Lippincott Williams and Wilkins; 2002:805-830.
3. Heaney RP: Bone health. Am J Clin Nutr 2007, 85:300S-303S.
4. Wagner C, Greer FR: Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008, 122:1142-1152.
5. Cranney A, Weiler HA, O'Donnell S, Puil L: Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 2008, 88:513S-519S.
6. Roux C, Bischoff-Ferrari HA, Papapoulos SE, et al.: New insights into the role of vitamin D and calcium in osteoporosis management: An expert roundtable discussion. Curr Med Res Opin 2008, 24:1363-1370.
7. Brannon PM, Yetley EA, Bailey RL, Picciano MF: Overview of the conference "Vitamin D and Health in the 21st Century: An Update." Am J Clin Nutr 2008, 88:483S-490S.
8. Wang-Gillam A, Miles DA, Hutchins LF: Evaluation of vitamin D deficiency in breast cancer patients on bisphosphonates. Oncologist 2008, 13:821-827.
9. Fleischer J, Stein EM, Bessler M, et al.: The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 2008, 93:3735-3740.
10. Adami S, Giannini S, Bianchi G, et al.: Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2008 Jun 13 (Epub ahead of print).
11. Holick MF, Biancuzzo RM, Chen TC, et al.: Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93:677-681.
12. Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
13. Trang HM, Cole DE, Rubin LA, et al.: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854-858.
14. Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
15. Hill KM, Braun M, Kern M, et al.: Predictors of calcium retention in adolescent boys. J Clin Endocrinol Metab 2008, 93:4743-4748.
16. Esterle L, Sabatier JP, Guillon-Metz F, et al.: Milk, rather than other foods, is associated with vertebral bone mass and circulating IGF-1 in female adolescents. Osteoporos Int 2008 Aug 14 (Epub ahead of print).
17. Bischoff-Ferrari HA, Rees JR, Grau MV, et al.: Effect of calcium supplementation on fracture risk: A doubleblind randomized controlled trial. Am J Clin Nutr 2008, 87:1945-1951.
18. Zhu K, Bruce D, Austin N, et al.: Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res 2008, 23:1343-1348.
19. Prince RL, Austin N, Devine A, et al.: Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008, 168:103-108.
20. Zhu K, Devine A, Dick IM, et al.: Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: A five-year randomized controlled trial. J Clin Endocrinol Metab 2008, 93:743-749.
21. Bolland MJ, Barber PA, Doughty RN, et al.: Vascular events in healthy older women receiving calcium supplementation: Randomised controlled trial. BMJ 2008, 336:262-266.
22. Heaney RP: Calcium supplementation and incident kiAney stone risk: a systematic review. J Am Coll Nutr 2008, 27:519-527.
23. Van Summeren MJ, van Coeverden SC, Schurgers LJ, et al.: Vitamin K status is associated with childhood bone mineral content. Br J Nutr 2008, 100:852-858.
24. Booth SL, Dallal G, Shea MK, et al.: Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008, 93:1217-1223.
25. Cheung AM, Tile L, Lee Y, et al.: Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): A randomized controlled trial. PLoS Med 2008, 5:e196.
26. Knapen MH, Schurgers LJ, Vermeer C: Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 2007, 18:963-972.
27. Beulens JW, Bots ML, Atsma F, et al.: High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2008 Jul 19 (Epub ahead of print).
28. Tucker KL, Chen H, Hannan MT, et al.: Bone mineral density and dietary patterns in older adults: The Framingham Osteoporosis Study. Am J Clin Nutr 2002, 76:245-252.
29. Sahni S, Hannan MT, Gagnon D, et al.: High vitamin C intake is associated with lower 4-year bone loss in elderly men. J Nutr 2008, 138:1931-1938.
30. Cassidy A, Albertazzi P, Lise Nielsen I, et al.: Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006, 65:76-92.
31. Zhang Y, Chen WF, Lai WP, Wong MS: Soy isoflavones and their bone protective effects. Inflammopharmacology 2008 Sep 26 (Epub ahead of print).
32. Brink E, Coxam V, Robins S, et al.: Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: A randomized, double-blind, placebo controlled study. Am J Clin Nutr 2008, 87:761-770.
33. Morabito N, Crisafulli A, Vergara C, et al.: Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002, 17:1904-1912.
34. Marini H, Minutoli L, Polito F, et al.: Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: A randomized trial. Ann Intern Med 2007, 146:839-847.
35. Marini H, Minutoli L, Polito F, et al.: OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res 2008, 23:715-720.
36. D'Anna R, Cannata ML, Atteritano M, et al.: Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: A 1-year randomized, double-blind, placebo-controlled study. Menopause 2007, 14:648-655.
37. Atteritano M, Pernice F, Mazzaferro S, et al.: Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study. Eur J Pharmacol 2008, 589:22-26.